Leica Biosystems completes acquisition of StatLab to bolster delivery of more precise, timely diagnostics for cancer patients

Leica Biosystems, a Danaher company (the “Company”) and a global leader in digital and anatomic pathology solutions advancing precision cancer diagnostics, announced today that the Company has completed its acquisition of privately held StatLab Medical Products (“StatLab”).

Leave a Reply